Our findings demonstrated that FHL2 supplementation after tendon injury can noticeably decrease YAP1/sFRP2 expression, inhibit vascular remodeling associated with tendinopathy and restore tissue structure despite some differences from normal tendon tissue. The gene discussed is FHL2; the disease is disease of the tendon.